Table 3 Comparison between PSA patients with and without biologic therapy as regards WBCs, RBCs, platelets indices

WBCS

6.135

 ± 

2.029

6.770

 ± 

2.174

 − 1.090

0.280

Neutrophils

3.815

 ± 

1.521

4.315

 ± 

1.601

 − 1.159

0.251

Lymphocytes

1.858

 ± 

0.538

2.061

 ± 

0.624

 − 1.245

0.218

HCT

36.590

 ± 

1.836

37.338

 ± 

1.372

 − 1.773

0.081

RBCs

4.895

 ± 

0.669

4.742

 ± 

0.449

1.052

0.297

Hb

12.380

 ± 

1.010

12.710

 ± 

1.142

 − 1.095

0.278

MCV

79.830

 ± 

10.495

80.438

 ± 

4.866

 − 0.308

0.759

MCH

25.350

 ± 

4.261

24.725

 ± 

3.860

0.571

0.570

RDW%

14.640

 ± 

2.205

13.163

 ± 

1.741

2.832

0.006*

PLT

265.250

 ± 

79.122

239.125

 ± 

68.786

1.319

0.192

MPV/fl

8.605

 ± 

0.984

8.710

 ± 

1.058

Gve3

0.712

PDW

11.325

 ± 

2.085

12.255

 ± 

2.673

 − 1.361

0.179

Hb/PLT ratio

0.049

 ± 

0.014

0.058

 ± 

0.018

 − 1.885

0.064

RDW%/PLT ratio

0.058

 ± 

0.016

0.060

 ± 

0.019

 − 0.359

0.721

RBCs/PLT ratio

0.020

 ± 

0.005

0.021

 ± 

0.006

 − 0.770

0.444

Hb/RDW% ratio

0.864

 ± 

0.156

0.979

 ± 

0.138

 − 2.914

0.005*

Neutrophil/lymphocyte ratio

2.058

 ± 

0.500

2.107

 ± 

0.492

 − 0.366

0.716

PLT/lymphocyte ratio

150.143

 ± 

51.290

124.882

 ± 

45.896

1.933

0.058